NEWwbztv-small wbz-am-small 985-small mytv38web2

Genzyme

boston skyline - thinkstock

Sanofi-Aventis Sees A Bright Future In Boston-Cambridge

Sanofi CEO Chris Viehbacher says research departments have been consolidated here to be near universities.

2012/04/30

Harvard's Innovation Lab (Photo courtesy: Kyle Alspach, Boston Business Journal)

Business Headlines: Harvard’s Innovation Lab; More Foreign Students

Harvard University is stepping up its efforts to innovate.

2011/11/15

Genzyme headquarters

How Genzyme Became Vulnerable To Sale

Analysts say Genzyme’s decision to manufacture a third drug at it’s Allston facility eventually led to its sale.

2011/02/28

(AP Graphic

It’s A Done Deal For Genzyme

After nine months of denials, rejection, bickering and finally, discussion, French pharmaceutical company Sanofi-Aventis of Paris has signed a deal to buy Genzyme of Cambridge for $20.1 billion plus other milestone payments in the future.

2011/02/16

Genzyme headquarters

Genzyme Sold To Sanofi-Aventis In $20 Billion Deal

Cambridge-based biotechnology company Genzyme is being bought by French drug maker Sanofi-Aventis for $20.1 billion, ending months of corporate haggling.

2011/02/16

wallstreetgraphicxl(cbs)

Before The Bell – Genzyme Sold

WBZ News Radio’s Bob Gough, in for Financial Editor Dave Caruso takes a look at the sale of Cambridge-based Genzyme.

WBZ NewsRadio 1030–2011/02/16

Genzyme headquarters

Genzyme Rejects Latest Sanofi Offer

Sanofi-Aventis extended its unsolicited $18.5 billion takeover offer for Cambridge biotech company Genzyme Corp. Monday.

2010/12/13

(credit: AP)

Patrick Admin. Denies Asking Raytheon To Delay Layoff Announcement

Raytheon announced a series of layoffs Tuesday just days after Gov. Deval Patrick denied asking it to delay terminations until after the election.

2010/11/10

Genzyme headquarters

Job Cuts Begin At Genzyme

Biotechnology company Genzyme is cutting 392 positions as it starts the first phase of a plan to eliminate 1,000 by the end of next year.

2010/11/06

Talk of possible Genzyme sale heating up

The Cambridge biotech company is being pursued by French drug company Sanofi-Aventis.  WBZ New England Business Editor Anthony Silva talked with Ken Bredemeier,  senior health care reporter at The Deal.

2010/08/03

Listen Live!

Follow CBS Boston

Like us on foursquare

Select a Live Stream